ibuprofen has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gui, Y; Hollenberg, M; Loutzenhiser, K; Loutzenhiser, R; Trottier, G; Wang, X | 1 |
1 other study(ies) available for ibuprofen and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
Article | Year |
---|---|
PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions.
Topics: Acetylcholine; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arterioles; Enzyme Inhibitors; Hydronephrosis; Ibuprofen; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Receptors, Thrombin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasodilation | 2002 |